NCT05837429

Brief Summary

Patients included in the study will be randomly divided into 2 groups using appropriate randomization programs. All patients will be given exercise training individually for 24 sessions using a bicycle ergometer under the supervision of a physiotherapist.Patients in the first group will be given exercise training on a bicycle ergometer for 5 minutes warm-up phase at 40% of maximal oxygen consumption (VO2max), 20 minutes exercise phase at 60% of VO2max and 5 minutes cool down phase at 40% of VO2max for a total of 30 minutes. Patients in the second group will be given a warm-up phase for 3 minutes at 50% VO2max, 1 minute at 80-100% VO2max and 1 minute at 50% VO2max in 10 cycles, and finally a cool-down phase for 3 minutes at 50% VO2max. In total, 25 minutes of low-volume high-intensity intermittent exercise training will be given on a bicycle ergometer.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable lung-cancer

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 6, 2023

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

April 15, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 1, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 6, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 6, 2025

Completed
Last Updated

July 18, 2024

Status Verified

July 1, 2024

Enrollment Period

2 years

First QC Date

April 15, 2023

Last Update Submit

July 17, 2024

Conditions

Keywords

Low volume high intensity interval trainingAerobic exerciseOxidative stressCardiopulmonary exercise test

Outcome Measures

Primary Outcomes (4)

  • Maximal oxygen consumption

    To be measured during cardiopulmonary exercise testing

    24 months

  • Heart Rate Variability

    To be measured during cardiopulmonary exercise testing

    24 months

  • Oxidative Stress

    Lipid peroxidation marker from serum for determination of oxidative damage melondialdehyde (MDA), total oxidant status (TOS), total antioxidant status (TAS) parameters will be evaluated.

    24 months

  • Myokine

    Irisin levels in serum, enzyme-linked immunosorbent assay (Enzyme-Linked Immuno Sorbent Assay-ELISA) method using a commercial kit.

    24 months

Secondary Outcomes (3)

  • Change in quality of life

    24 months

  • Peripheral Muscle Strength

    24 months

  • Activity of Daily Living

    24 months

Study Arms (2)

Low Volume High Intensity Exercise Training

EXPERIMENTAL

Patients in the intervention group will be given a warm-up phase for 3 minutes at 50% VO2max, 1 minute at 80-100% VO2max and 1 minute at 50% VO2max in 10 cycles, and finally a cool-down phase for 3 minutes at 50% VO2max.

Behavioral: Low Volume High Intensity Exercise Training

Aerobic Exercise

ACTIVE COMPARATOR

Patients in the control group will be given exercise training on a bicycle ergometer for 5 minutes warm-up phase at 40% of maximal oxygen consumption (VO2max), 20 minutes exercise phase at 60% of VO2max and 5 minutes cool down phase at 40% of VO2max for a total of 30 minutes.

Behavioral: Aerobic Exercise Training

Interventions

Patients in the intervention group will be given a warm-up phase for 3 minutes at 50% VO2max, 1 minute at 80-100% VO2max and 1 minute at 50% VO2max in 10 cycles, and finally a cool-down phase for 3 minutes at 50% VO2max.

Low Volume High Intensity Exercise Training

Patients in the control group will be given exercise training on a bicycle ergometer for 5 minutes warm-up phase at 40% of maximal oxygen consumption (VO2max), 20 minutes exercise phase at 60% of VO2max and 5 minutes cool down phase at 40% of VO2max for a total of 30 minutes.

Aerobic Exercise

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with Non-Small Cell Lung Cancer
  • Stage 3A and earlier
  • Operated and at least 6 months have expired since the surgery
  • Having completed adjuvant treatments such as chemotherapy and radiotherapy and at least 6 months have expired
  • Being clinically stable and in remission
  • Not having new recurrence and active cancer

You may not qualify if:

  • Pneumonectomy surgery
  • Presence of symptoms, signs and diagnoses indicating the presence of lung and cardiac disease such as advanced COPD
  • Having any orthopedic or neurological problem that may prevent exercise
  • Presence of recurrence or active cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara University

Ankara, Sıhhiye, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Lung NeoplasmsCarcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesCarcinoma, BronchogenicBronchial Neoplasms

Study Officials

  • Hamide Sahin-Yildiz, Msc,PT

    Ankara University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hamide Sahin-Yildiz, Msc,PT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, PT, Msc

Study Record Dates

First Submitted

April 15, 2023

First Posted

May 1, 2023

Study Start

April 6, 2023

Primary Completion

April 6, 2025

Study Completion

April 6, 2025

Last Updated

July 18, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations